Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |